Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity

Navin R. Mahadevan, Erik H. Knelson, Jacquelyn O. Wolff, +39

Cancer Discovery

A Novel Epigenetic Signature for Early Diagnosis in Lung Cancer

Ángel Díaz‐Lagares, Jesús Méndez‐González, David Hervás, +10

Clinical Cancer Research

<i>MET</i> -Oncogenic and <i>JAK2</i> -Inactivating Alterations Are Independent Factors That Affect Regulation of PD-L1 Expression in Lung Cancer

Maria Saigí, Juan J. Alburquerque-Béjar, Anne Mc Leer‐Florin, +8

Clinical Cancer Research

SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade

Octavio A. Romero, Andrea Vilarrubi, Juan J. Alburquerque-Béjar, +17

Nature Communications

Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors

Eva Pros, Maria Saigí, Daniel Alameda, +22

Annals of Oncology

Radiation OncologyMedicineCancer GenomicsEgfr-mutant TumorsBronchial Neoplasm +9

MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer

Ryohei Yoshida, Maria Saigí, Tetsuo Tani, +21

Cancer Research

Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

M.A. Bergamino, Antonio Rullan, Maria Saigí, +11

BMC Cancer

MYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer

Juan J. Alburquerque-Béjar, P. Navajas-Chocarro, Maria Saigí, +15

Cell Reports Medicine

Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma

Elisabet Aliagas, Ania Alay, María Martínez‐Iniesta, +23

British Journal of Cancer

OncologyMalignant Pleural MesotheliomaMalignant DiseasePreclinical ModelsMedicine +9

Genetic screening and molecular characterization of MET alterations in non-small cell lung cancer

Maria Saigí, Anne McLeer‐Florin, Eva Pros, +3

Clinical & Translational Oncology

Molecular CharacterizationOncogenic AgentMedicinePathologyCancer Genomics +11